Trilliant Health, a Nashville, TN.-based healthcare analytics company that empowers intelligence patient acquisition has raised $12 million in Series A funding led by Noro-Moseley Partners, with participation from existing investors Martin Ventures, Nashville Capital Network, and NueCura Partners. Trilliant Health plans to use the funding to continue building its data science and technology teams to enhance the capabilities of its analytics platform
Founded by 2017, Trilliant provides an analytics platform that uses advanced data science to combine claims data, household data, and user-generated data from digital marketing campaigns to support healthcare systems around strategy, site selection, M&A, payer negotiations, physician relationship management, marketing, and employer relationship management. Today, the company works with over 60 healthcare systems across the nation to build and execute on their growth strategies.
“Trilliant Health turns analytics into highly differentiated insights and intelligence to help healthcare providers better understand their individual market dynamics,” said Spence McClelland, General Partner at Noro-Moseley Partners. “The Trilliant leadership team and investor group have some of the strongest backgrounds and expertise in healthcare. This healthcare experience, combined with the deep bench of data science, technology, and product teams, positions Trilliant to transform the way healthcare systems approach growth. If I were a healthcare system executive needing to grow revenue and market share, I would seek a trusted advisor that has a proven track record.”
